Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
213.81
-3.78 (-1.74%)
Mar 17, 2026, 12:41 PM EDT - Market open
Cardinal Health Stock Forecast
Stock Price Forecast
The 11 analysts that cover Cardinal Health stock have a consensus rating of "Buy" and an average price target of $230.45, which forecasts a 7.79% increase in the stock price over the next year. The lowest target is $186 and the highest is $258.
Price Target: $230.45 (+7.79%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cardinal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Buy | 7 | 6 | 7 | 7 | 7 | 7 |
| Hold | 4 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 11 | 12 | 12 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $243 → $258 | Buy | Maintains | $243 → $258 | +20.67% | Feb 24, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $209 → $243 | Hold | Maintains | $209 → $243 | +13.65% | Feb 10, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $237 → $256 | Buy | Maintains | $237 → $256 | +19.74% | Feb 10, 2026 |
| Mizuho | Mizuho | Buy Maintains $222 → $235 | Buy | Maintains | $222 → $235 | +9.91% | Feb 6, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $224 → $245 | Buy | Maintains | $224 → $245 | +14.59% | Jan 29, 2026 |
Financial Forecast
Revenue This Year
261.25B
from 222.58B
Increased by 17.38%
Revenue Next Year
284.76B
from 261.25B
Increased by 9.00%
EPS This Year
10.41
from 6.45
Increased by 61.37%
EPS Next Year
11.69
from 10.41
Increased by 12.35%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 276.7B | 307.7B | |||
| Avg | 261.3B | 284.8B | |||
| Low | 250.8B | 267.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 24.3% | 17.8% | |||
| Avg | 17.4% | 9.0% | |||
| Low | 12.7% | 2.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.95 | 12.34 | |||
| Avg | 10.41 | 11.69 | |||
| Low | 10.00 | 11.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 69.8% | 18.5% | |||
| Avg | 61.4% | 12.3% | |||
| Low | 55.0% | 6.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.